search
Back to results

NMES to Prevent Respiratory Muscle Atrophy in Mechanically Ventilated Patients

Primary Purpose

Mechanical Ventilation Complication, Neuromuscular Electrical Stimulation, Muscle Weakness

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
VentFree prototype (VF03-K) active stimulation
VentFree prototype (VF03-K) sham stimulation
Sponsored by
University Medical Center Nijmegen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Mechanical Ventilation Complication focused on measuring Expiratory muscles, Mechanically ventilated patients, Neuromuscular electrical stimulation, Respiratory function, Ventilator-acquired muscle atrophy

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age > 18 year
  • invasive mechanical ventilation less than 72 hours
  • expected duration of MV after inclusion > 72 hours

Exclusion Criteria:

  • no clearly visible separate layers of the abdominal wall muscles (external oblique, internal oblique and transverse abdominal muscles), assessed with ultrasound during routine care
  • cardiac pacemaker
  • congenital myopathies and/or existing central or peripheral neuropathies
  • refractory epilepsy
  • recent abdominal surgery within four weeks prior to study inclusion
  • body mass index (BMI) greater than 35 kg/m2
  • pregnancy

Sites / Locations

  • UMC NijmegenRecruiting
  • Canisius Wilhelmina HospitalRecruiting
  • VU University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

VF03-K active stimulation

VF03-K sham stimulation

Arm Description

NMES applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner.

Sham stimulation applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Sham stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner.

Outcomes

Primary Outcome Measures

Thickness of the abdominal wall muscles
Thickness of the abdominal wall muscles over time, for both groups, as measured by ultrasound.

Secondary Outcome Measures

Thickness of the diaphragm
Thickness of the diaphragm over time, for both groups, as measured by ultrasound.
Thickness of the rectus abdominis muscle
Thickness of the rectus abdominis mucle over time, for both groups, as measured by ultrasound.
Maximum expiratory pressure (MEP)
Maximum expiratory pressure (MEP) to assess expiratory muscle function
Maximum inspiratory pressure (MIP)
Maximum inspiratory pressure (MIP) to assess inspiratory muscle function
Vital capacity (Vc)
Vital capacity (Vc) to assess respiratory muscle strength
Peak expiratory flow
Peak expiratory flow (PEF) to assess cough strength
Number of patients with extubation failure
Weaning failure defined as the failure to pass a spontaneous-breathing trial or the need for reintubation within 48 hours following extubation
Systemic inflammatory markers
Among others, cytokines IL-6 and IL-1 will be determined from blood sample analysis
Number of patients with respiratory complications after ICU discharge
Number of patients with development of pneumonia, and readmission to the ICU due to atelectasis or respiratory problems that require mechanical ventilation.

Full Information

First Posted
April 25, 2017
Last Updated
February 26, 2018
Sponsor
University Medical Center Nijmegen
Collaborators
Liberate Medical, Amsterdam UMC, location VUmc, Canisius-Wilhelmina Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03453944
Brief Title
NMES to Prevent Respiratory Muscle Atrophy in Mechanically Ventilated Patients
Official Title
Breath Synchronized Electrical Stimulation of the Abdominal Wall Muscles to Prevent Respiratory Muscle Atrophy During the Acute Stages of Mechanical Ventilation Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Unknown status
Study Start Date
March 9, 2017 (Actual)
Primary Completion Date
July 1, 2018 (Anticipated)
Study Completion Date
December 31, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Medical Center Nijmegen
Collaborators
Liberate Medical, Amsterdam UMC, location VUmc, Canisius-Wilhelmina Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients requiring prolonged time on the ventilator are susceptible to a wide range of clinical complications and excess mortality. It is therefore imperative for them to wean at the earliest possible time. Respiratory muscle weakness due to disuse of these muscles is a major underlying factor for weaning failure. Surprisingly, there is not much known about the impact of critical illness and MV on the expiratory abdominal wall muscles.These muscles are immediately activated as ventilation demands increase and are important in supporting respiratory function in patients with diaphragm weakness. Weakness of expiratory abdominal wall muscles will result in a decreased cough function and reduced ventilatory capacity. These are considerable causes of weaning failure and (re)hospitalisation for respiratory complications such as pneumonia. Recent evidence shows that neuromuscular electrical stimulation (NMES) can be used as a safe therapy to maintain skeletal muscle function in critically ill patients. This study will be the first to test the hypothesis that breath-synchronized NMES of the abdominal wall muscles can prevent expiratory muscle atrophy during the acute stages of MV.
Detailed Description
Approximately 30-40% of intubated patients at the intensive care unit (ICU) take more than one attempt to wean from mechanical ventilation (MV). 6-14% of intubated patients take longer than 7 days to wean from MV. Patients requiring prolonged time on the ventilator are susceptible to a wide range of clinical complications and excess mortality. It is therefore imperative for them to wean at the earliest possible time. Respiratory muscle weakness due to disuse of these muscles is a major underlying factor for weaning failure. It is known that diaphragm strength rapidly declines within a few days after the initiation of MV. Surprisingly, there is not much known about the impact of critical illness and MV on the expiratory abdominal wall muscles.These muscles are immediately activated as ventilation demands increase and are important in supporting respiratory function in patients with diaphragm weakness. Weakness of expiratory abdominal wall muscles will result in a decreased cough function and reduced ventilatory capacity. These are considerable causes of weaning failure and (re)hospitalisation for respiratory complications such as pneumonia. Recent evidence shows that neuromuscular electrical stimulation (NMES) can be used as a safe therapy to maintain skeletal muscle function in critically ill patients, e.g. by stimulating quadriceps muscles in patients receiving MV. This study will be the first to test the hypothesis that exhalation synchronized NMES of the abdominal wall muscles can prevent expiratory muscle atrophy during the acute stages of MV. The investigators hypothesize that this approach will improve respiratory function and thereby will reduce the amount of time it takes to wean patients from mechanical ventilation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mechanical Ventilation Complication, Neuromuscular Electrical Stimulation, Muscle Weakness
Keywords
Expiratory muscles, Mechanically ventilated patients, Neuromuscular electrical stimulation, Respiratory function, Ventilator-acquired muscle atrophy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
VF03-K active stimulation
Arm Type
Experimental
Arm Description
NMES applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner.
Arm Title
VF03-K sham stimulation
Arm Type
Sham Comparator
Arm Description
Sham stimulation applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Sham stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner.
Intervention Type
Device
Intervention Name(s)
VentFree prototype (VF03-K) active stimulation
Intervention Description
Abdominal wall muscle stimulation synchronised with mechanical ventilation. Stimulation frequency: 30 Hz, pulse width: 352us, max. intensity: 100mA (threshold intensity determined using ultrasound)
Intervention Type
Device
Intervention Name(s)
VentFree prototype (VF03-K) sham stimulation
Intervention Description
Abdominal wall muscle sham-stimulation synchronised with mechanical ventilation. Stimulation frequency: 10 Hz, pulse width: 352us, intensity: 15 mA.
Primary Outcome Measure Information:
Title
Thickness of the abdominal wall muscles
Description
Thickness of the abdominal wall muscles over time, for both groups, as measured by ultrasound.
Time Frame
Until study completion, up to 6 weeks
Secondary Outcome Measure Information:
Title
Thickness of the diaphragm
Description
Thickness of the diaphragm over time, for both groups, as measured by ultrasound.
Time Frame
Until study completion, up to 6 weeks
Title
Thickness of the rectus abdominis muscle
Description
Thickness of the rectus abdominis mucle over time, for both groups, as measured by ultrasound.
Time Frame
Until study completion, up to 6 weeks
Title
Maximum expiratory pressure (MEP)
Description
Maximum expiratory pressure (MEP) to assess expiratory muscle function
Time Frame
Within 24 hours after extubation
Title
Maximum inspiratory pressure (MIP)
Description
Maximum inspiratory pressure (MIP) to assess inspiratory muscle function
Time Frame
Within 24 hours after extubation
Title
Vital capacity (Vc)
Description
Vital capacity (Vc) to assess respiratory muscle strength
Time Frame
Within 24 hours after extubation
Title
Peak expiratory flow
Description
Peak expiratory flow (PEF) to assess cough strength
Time Frame
Within 24 hours after extubation
Title
Number of patients with extubation failure
Description
Weaning failure defined as the failure to pass a spontaneous-breathing trial or the need for reintubation within 48 hours following extubation
Time Frame
Within 24 hours after extubation
Title
Systemic inflammatory markers
Description
Among others, cytokines IL-6 and IL-1 will be determined from blood sample analysis
Time Frame
Within 24 hours after extubation
Title
Number of patients with respiratory complications after ICU discharge
Description
Number of patients with development of pneumonia, and readmission to the ICU due to atelectasis or respiratory problems that require mechanical ventilation.
Time Frame
Up to 6 weeks after ICU discharge
Other Pre-specified Outcome Measures:
Title
Expiratory flow limitation (optional)
Description
EFL test to determine flow limitation in COPD
Time Frame
Measured before the first NMES session and within 24 hours after extubation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age > 18 year invasive mechanical ventilation less than 72 hours expected duration of MV after inclusion > 72 hours Exclusion Criteria: no clearly visible separate layers of the abdominal wall muscles (external oblique, internal oblique and transverse abdominal muscles), assessed with ultrasound during routine care cardiac pacemaker congenital myopathies and/or existing central or peripheral neuropathies refractory epilepsy recent abdominal surgery within four weeks prior to study inclusion body mass index (BMI) greater than 35 kg/m2 pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leo MA Heunks, MD, Prof
Phone
0204442209
Email
l.heunks@vumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Annemijn H Jonkman, MSc
Phone
0204442209
Email
ah.jonkman@vumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Angelique ME Spoelstra-de Man, MD, PhD
Organizational Affiliation
Amsterdam UMC, location VUmc
Official's Role
Principal Investigator
Facility Information:
Facility Name
UMC Nijmegen
City
Nijmegen
State/Province
Gelderland
ZIP/Postal Code
6525 GA
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tim Frenzel, MD, PhD
Phone
+31 (0) 24 3665010
Email
tim.frenzel@radboudumc.nl
Facility Name
Canisius Wilhelmina Hospital
City
Nijmegen
State/Province
Gelderland
ZIP/Postal Code
6532 SZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jeroen Schouten, MD
Phone
+31 (0)24 - 365 7915
Email
j.schouten@cwz.nl
First Name & Middle Initial & Last Name & Degree
Mirjam Evers
Phone
+31 (0)24 - 365 7915
Email
m.evers@cwz.nl
Facility Name
VU University Medical Center
City
Amsterdam
State/Province
Noord-Holland
ZIP/Postal Code
1081 HV
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leo MA Heunks, MD, Prof
Email
l.heunks@vumc.nl
First Name & Middle Initial & Last Name & Degree
Angelique ME Spoelstra-de Man, MD, PhD
Email
am.spoelstra@vumc.nl
First Name & Middle Initial & Last Name & Degree
Annemijn Jonkman, MSc

12. IPD Sharing Statement

Citations:
PubMed Identifier
33126902
Citation
Jonkman AH, Frenzel T, McCaughey EJ, McLachlan AJ, Boswell-Ruys CL, Collins DW, Gandevia SC, Girbes ARJ, Hoiting O, Kox M, Oppersma E, Peters M, Pickkers P, Roesthuis LH, Schouten J, Shi ZH, Veltink PH, de Vries HJ, Shannon Weickert C, Wiedenbach C, Zhang Y, Tuinman PR, de Man AME, Butler JE, Heunks LMA. Breath-synchronized electrical stimulation of the expiratory muscles in mechanically ventilated patients: a randomized controlled feasibility study and pooled analysis. Crit Care. 2020 Oct 30;24(1):628. doi: 10.1186/s13054-020-03352-0.
Results Reference
derived

Learn more about this trial

NMES to Prevent Respiratory Muscle Atrophy in Mechanically Ventilated Patients

We'll reach out to this number within 24 hrs